Tiered therapy for respiratory oscillations characteristic of Cheyne-Stokes respiration

• US 7,519,425 B2
• Filed: 10/18/2004
• Issued: 04/14/2009
• Est. Priority Date: 01/26/2004
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Benser, Michael, Falkenberg, Eric
• Primary Examiner(s): Manuel; George
• Application Number:
  US10/968,730
• Publication Number:
  US 20050165457A1
• Time in Patent Office: 1,639 Days
• Field of Search: 600/26, 600/27, 600/484, 600/529, 600531-538, 600/547
• US Class Current: 607/42
• CPC Class Codes: A61N 1/3601 of respiratory organs
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585

Abstract

An exemplary method includes delivering a maintenance therapy that aims to prevent occurrence of apnea, sensing information, based at least in part on the information, determining if apnea exists and, if apnea exists, delivering a termination therapy that aims to terminate the apnea. An exemplary implantable device includes an input for information pertaining to respiration and control logic to call for overdrive pacing at a first rate that aims to minimize occurrence of a respiratory condition, to analyze the information for occurrence of the respiratory condition and, upon occurrence of the respiratory condition, to call for overdrive pacing at a higher rate. Other exemplary methods, devices, systems, etc., are also disclosed.

Claims

1. A method comprising:

at a time corresponding to patient rest and in the absence of sleep apnea, delivering a maintenance therapy that aims to prevent sleep apnea, the maintenance therapy comprising cardiac overdrive pacing at a first overdrive rate in excess of a cardiac base rate, a cardiac paced rate or a cardiac intrinsic rate, where the overdrive pacing rate corresponds to an interval between atrial or ventricular pacing pulses;

sensing information during delivery of the maintenance therapy;

based at least in part on the information, determining if apnea comes into existence during delivery of the maintenance therapy; and

if apnea comes into existence, stopping delivery of the maintenance therapy and delivering a termination therapy comprising overdrive pacing at a second overdrive rate in excess of the first overdrive rate.

2. The method of claim 1 further comprising classifying the apnea as being related to central apnea or obstructive apnea.

3. The method of claim 1 wherein delivering termination therapy further comprises delivering diaphragm activation.

4. The method of claim 1 wherein a time corresponding to patient rest is determined according to a schedule.

5. The method of claim 1 wherein a time corresponding to patient rest is determined by position information of a patient.

6. The method of claim 1 wherein a time corresponding to patient rest is determined by activity information of a patient.

7. The method of claim 1 further comprising adjusting one or more parameters associated with the maintenance therapy in response to the determining.

8. The method of claim 1 wherein overdrive pacing is delivered at a constant rate as a function of time.

9. The method of claim 1 wherein overdrive pacing is delivered at a nonconstant rate as a function of time.

10. The method of claim 9 wherein the nonconstant rate comprises one or more of an exponentially decaying component and a sine shaped component.

11. A method comprising:

at a time corresponding to patient rest and in the absence of sleep apnea, delivering a maintenance therapy that aims to prevent sleep apnea, the maintenance therapy comprising cardiac overdrive pacing at a first overdrive rate in excess of a cardiac base rate, a cardiac paced rate or a cardiac intrinsic rate;

sensing information during delivery of the maintenance therapy;

based at least in part on the sensed information, determining if apnea comes into existence during delivery of the maintenance therapy; and

if apnea comes into existence, stopping delivery of the maintenance therapy and delivering a termination therapy comprising diaphragm activation.

12. A method comprising:

at a time corresponding to patient rest and in the absence of hypopnea, delivering a maintenance therapy comprising cardiac overdrive pacing at a first overdrive rate in excess of a cardiac base rate, a cardiac paced rate or a cardiac intrinsic rate, that aims to prevent occurrence of hypopnea;

sensing information during delivery of the maintenance therapy;

based at least in part on the information, determining if hypopnea comes into existence during delivery of the maintenance therapy; and

if hypopnea comes into existence, stopping delivery of the maintenance therapy and delivering a termination therapy that aims to terminate the hypopnea.

13. The method of claim 12 wherein the termination therapy comprises overdrive pacing at a second overdrive rate in excess of the first overdrive rate.

14. The method of claim 12 wherein the sensing information comprises sensing information related to airway patency.

15. The method of claim 12 further comprising delivering diaphragm activation if the termination therapy fails to terminate the hypopnea.

16. The method of claim 12 wherein a time corresponding to patient rest is determined according to a schedule.

17. The method of claim 12 a time corresponding to patient rest is determined by position information of a patient.

18. The method of claim 12 wherein a time corresponding to patient rest is determined by activity information of a patient.

19. The method of claim 12 further comprising adjusting one or more parameters associated with the maintenance therapy in response to the determining.

20. The method of claim 12 wherein the termination therapy comprises diaphragm activation.

21. The method of claim 12 wherein the maintenance therapy comprises diaphragm activation.